Finally, we studied the recently described MuRF1-inhibiting small molecules in DIO mice, because we wanted to determine if the muscle-protective effects from “atrogene” inhibition or potential pro-diabetic effects dominate in T2DM in this context. This evidence concerns the gene TRIM63 and type 2 diabetes mellitus.